COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20200406046963N2


Column Value
Trial registration number IRCT20200406046963N2
Full text link
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Ramin Hamidi Farahani

Contact
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Rgsramin@yahoo.com

Registration date
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-07-31

Recruitment status
Last imported at : Sept. 19, 2021, 1:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Open label

Center
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Patient with moderate to severe Covid-19 admitted to ICU PaO2/FiO2 Less than 300 LDH more than 450 Progression of disease severity and not responding to standard treatment prediction of intubation for next 24 hours

Exclusion criteria
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Uncontrolled diabetes mellitus Active GI bleeding history of corticosteroid hypersensitivity sever electrolyte imbalances Procalcitonin more than 0.5 active bacterial, viral ( HIV, Hepatitis) and fungal infection

Number of arms
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Artesh University of Medical Sciences

Inclusion age min
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

90

Countries
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe disease at enrollment

Severity scale
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

40

primary outcome
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Mortality rate

Notes
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : July 31, 2021, 2:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 1807, "treatment_name": "Adalimumab+methylprednisolone", "treatment_type": "Other targeted therapies+corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]